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ABSTRACT 
This work reports an amperometric enzyme-electrode prepared with glucose 
oxidase, which have been immobilized by a cross-linking step with glutaraldehyde 
in a mixture containing albumin and a novel carbon nanotubes-mucin composite 
(CNT-muc). The obtained hydrogel matrix was trapped between two polycarbonate 
membranes and then fixed at the surface of a Pt working electrode. The developed 
biosensor was optimized by evaluating different compositions and the analytical 
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properties of an enzymatic matrix with CNT-muc. Then, the performance of the 
resulting enzymatic matrix was evaluated for direct glucose quantification in human 
blood plasma. 
The novel CNT-muc composite provided a sensitivity of 0.44 ± 0.01 mA.M−1 
and a response time of 28 ± 2 s. These values were respectively 20% higher and 
40% shorter than those obtained with a sandwich-type biosensor prepared without 
CNT. Additionally, CNT-muc based biosensor exhibited more than 3 orders of 
magnitude of linear dynamic calibration range and a detection limit of 3 µM. The 
short-term and long-term stabilities of the biosensors were also examined and 
excellent results were obtained through successive experiments performed within 
the first 60 days from their preparation. Finally, the storage stability was 
remarkable during the first 300 days.  
Keywords: NOVEL HYDROGEL, CARBON NANOTUBES, MUCIN, GLUCOSE 
OXIDASE, BIOSENSOR, HUMAN PLASMA. 
 
1. INTRODUCTION  
The determination of glucose concentration is very important for early 
diagnostic and management of Diabetes. Diabetes mellitus is a pathology widely 
distributed around the world, with estimations of 300 million sufferers throughout 
the world by 2045 [1]. It is characterized by deranged blood glucose levels and 
metabolic abnormalities associated with numerous macro and microvascular 
sequelae as well as additional co-morbidities, because of insufficient or ineffective 
endogenous insulin. Therefore, methodologies that ensure efficient glucose 
quantification are highly required for early diagnosis of Diabetes as well as for its 
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management control in the public health system [2, 3]. 
The development of biosensors has potential because they are cheap, 
sensitive, selective, and simple operation analytical tools. Since the first enzymatic 
glucose biosensor, different strategies have been proposed for the development of 
these bio-detection platforms [4, 5]. In this sense, the electrochemical ones have 
demonstrated to be highly successful due to their known advantages. Among 
them, amperometric enzyme electrodes mainly based on glucose oxidase (GOx) 
have gained considerable attention. GOx catalyzes the oxidation of glucose to 
gluconolactone in the presence of the natural mediator, oxygen, and generates 
hydrogen peroxide that is then subsequently oxidized at the working electrode 
producing a current proportional to analyte concentration [6-9]. The amperometric 
determination of hydrogen peroxide has been the most commonly used in 
electrochemical transduction mode. The proposed mechanism involves diffusion of 
the glucose to GOx within the network of a hydrogel, with subsequent enzymatic 
reaction and production of H2O2 and gluconic acid. The hydrogen peroxide 
produced is transported by diffusion to the working Pt electrode where it is oxidized 
[10-15]. 
Selectivity, stability, and cost of amperometric enzyme biosensors are key 
parameters for creating effective analytical systems intended for operation with real 
samples. Generally, enzymes do not have long term stability in aqueous medium, 
thus immobilization techniques play a critical role in stabilizing GOx and other 
enzymes. Generally, enzymes don’t have long term stability in aqueous media, 
thus immobilization techniques play a critical role in stabilizing GOx and other 
enzymes.  In this sense, the enzymatic matrix determines the enzyme stability and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
the overall analytical performance of an amperometric biosensor. Moreover, the 
possibility of avoiding these limitations will improve the useful life of a biosensor [7]. 
One of the most interesting materials in this regard are carbon nanotubes (CNTs). 
They have been extensively studied for the development of electrochemical 
biosensors due to their exceptional properties like high aspect ratio, adsorption of 
molecules, reactivity, thermal stability, flexibility, and electronic conductivity [16]–
[18]. Despite of their unique and interesting characteristics, CNTs tend to 
aggregate in aqueous media because of their high surface area and strong π-π 
interactions between their aromatic rings. Nevertheless, stable aqueous 
suspensions of CNTs were generated by forming a supramolecular structure with 
the hyperbranched polymer BH40 in a previous study [19]. With a similar approach, 
a natural macromolecule suitable for immobilization of enzymes [12], [14], [20]. 
such as mucin could be used in combination with CNTs to obtain stable 
suspension with optimal properties as enzymatic matrix.  
In this manuscript, a novel carbon nanotubes-mucin composite (CNT-muc) 
has been synthesized and then used to prepare the enzymatic matrix of a glucose 
biosensor. According to our experience, the inclusion of CNT into the enzymatic 
matrix would contribute to enhance the diffusion of reactive species and thus, to 
improve the response time of sandwich-type biosensors. Accordingly, the CNT-
muc composite was mixed with albumin (alb) and GOx and then crosslinked with 
glutaraldehyde. After optimizing the composition of the enzymatic matrix, a 
biosensor with excellent analytical characteristics was obtained. The resulting 
biosensor was finally used for determining the glucose concentration of diverse 
human blood plasma samples. 
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2. EXPERIMENTAL SECTION  
2.1. Reagents 
Phosphate buffer solution pH 7.0 was employed as base electrolyte. This 
electrolyte solution (0.1 M) was prepared by mixing 0.05 M HK2PO4 / 0.05 M 
H2KPO4 (Merck, Germany). Then, the solution was fixed at pH 7.0 with small 
amounts of H2SO4 (Baker, USA) or KOH (Merck, Germany) and renewed weekly. 
Hydrogen peroxide (30% v/v aqueous solution) was purchased from (Cicarelli, 
Argentina). Glucose was from Merck and AA was from Sigma. GOx (Type X-S, 
Aspergillus Niger, EC 1.1.3.4, and 100.000 Units per gram of solid, Catalog 
number G-7141, Sigma, USA) was dissolved in 510 µL of base electrolyte to get a 
solution with 4.0 U µL−1 of GOx. From this solution, 5 aliquots of 20 µL were 
separated into vials and stored at −20 °C. The rema ining solution was further 
diluted to prepare aliquots of 20 µL with 20 U of GOx. These aliquots were also 
stored at −20 °C. Solutions of glutaraldehyde (Backer, USA) w ere prepared in base 
electrolyte. Bovine serum albumin (Sigma, USA) was used as received. Mucin was 
supplied by Sigma, USA. It was dried in an oven at 37 °C during 24 h. After this 
period, it was stored at 4 °C. CNT (Sunnano, China)  with diameter that ranges 
between 30 and 10 nm was used as received. CNT-muc mixture was prepared 
weighing 10% CNT and 90% mucin. Both were put in a mortar and grinded into a 
fine powder by 30 minutes. The CNT-muc mixture was dried in an oven at 37 °C by 
24 h and stored at 4 °C until use. 
All other reagents were of analytical grade and used as received. 
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Polycarbonate membranes of 0.05 µm pore size (Millipore, USA) were cut in discs 
of 6 mm in diameter. Ultrapure water (σ =18 MΩ.cm) from a Millipore-MilliQ system 
was used for preparing all the solutions.  
 
2.2. Apparatus 
The electrochemical measurements were performed with an Autolab 
PGSTAT 30 Electrochemical Analyzer (Eco Chemie, The Netherlands). The 
working electrode was a 2 mm diameter Pt disk (CH Instruments, USA). 
Furthermore, a platinum wire and a Ag|AgCl|KCl(3M) (CH Instruments) were used 
as counter and reference electrodes, respectively. All potentials are referred to the 
latter. In all assays, a magnetic stirrer provided the convective transport during the 
amperometric measurements. 
 
2.3. Preparation of the enzymatic matrix 
The matrix was prepared by dissolving 6.0 mg of different mass ratios of 
CNT-muc and albumin in 40 µL of base electrolyte. It was mixed and sonicated for 
5 and 30 seconds, respectively. All the proportions of CNT-muc and albumin 
resulted in a homogeneous dark black dispersion in which no type of precipitate or 
aggregate was observed. Then, a vial containing 20 µL of GOx was incorporated to 
the matrix and mixed for additional 60 seconds. The resulting volume of enzymatic 
matrix was mixed for extra 5 min and stored at 4 °C .  
 
2.4. Construction of the enzymatic electrode 
For this, a 4 µL of enzymatic matrix was mixed with 3 µL of glutaraldehyde 
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and placed between two membranes of polycarbonate. Subsequently, it was 
placed with precision tweezers at the surface of the Pt working electrode and fixed 
with a suitable cap. After 5 min, buffer solution was used to rinse the electrode and 
eliminate the excess of glutaraldehyde and other molecules that did not react with 
the polymeric matrix. Thus, 1.33 ± 0.01 U of GOx remains entrapped in each 
biosensor. This immobilization method not only produces the three-dimensional 
hydrogel matrix where the enzyme is trapped, but also provides an environment 
where the enzyme keeps most of its activity at proximity of the electrode surface. 
 
2.5. Procedure 
Amperometric measurements were conducted in a stirred (120 rpm) 0.10 M 
phosphate buffer solution pH 7.0 by applying the desired working potential and 
allowing the transient currents to decay to a steady-state value prior to the addition 
of the glucose and subsequent current monitoring. All measurements were 
performed at room temperature. After each calibration curve, the biosensor was 
rinsed with buffer pH 7.0.  
The glucose concentration of 10 serum samples was quantified at clinical 
laboratory of the Medical Centre of Unión Obrera Metalúrgica, Córdoba, Argentina 
by the standard bi-enzymatic method. Those samples were transferred to our 
laboratory and analyzed within 24 hs of their reception. 
For stability assays, two bioelectrodes stored at 4°C in PBS solution pH 7.0 
were analyzed. The analytical sensitivity was measured for 10 months and only 
decreased less 10% with respect to the original value, not shown. 
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3. RESULTS AND DISCUSSION 
 
3.1 Effect of the hydrogel composition 
Chronoamperometric experiments were performed to study the analytical 
performance of sandwich-type biosensors prepared with different enzymatic 
matrixes. Figure 1 shows the typical electrochemical response of a sandwich-type 
biosensor prepared with an enzymatic matrix composed by 1.33 U of GOx,           
10/90 % w/w of CNT-muc and albumin, respectively. A 10% v/v glutaraldehyde 
solution was added to crosslink the enzymatic matrix. The amperometric signal 
was measured at +0.65V vs. Ag|AgCl|KCl (3M). Every addition of glucose 
increased the concentration in 0.2 mM. The current signal increased immediately 
after each addition and then depicted a very stable limiting current (Ilim) response. 
As it can be observed from the inset of Figure 1, there is a linear relationship 
between Ilim and glucose concentration (CGluc). 
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Fig. 1. Chronoamperometric curve corresponding to successive 0.2 mM injections 
of glucose at a Pt electrode modified with an enzymatic matrix composed by 10% 
CNT-muc, 90% albumin, GOx 1.33 U/sensor and glutaraldehyde diluted to 10.0 % 
v/v. Inset: Dependence of the limiting current observed for each standard addition 
of glucose. 
 
Although the biosensor composed by 10% CNT-muc and 90% albumin 
presented a relatively good calibration curve, the composition of the enzymatic 
matrix still needs to be optimized to improve the performance of the biosensor. 
Figure 2 depicts 3D plots where the proportion of CNT-muc, albumin, and 
concentration of crosslinker agent are varied. The composition of the enzymatic 
matrix that maximizes the sensitivity (A) and minimizes the response time (B) of 
the sensor   was determined. The 3D plot shown in Figure 2 (A) corresponds to 
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the slope of calibration curves (Ilim.CGluc–1) measured with sandwich-type 
biosensors of different compositions, while the 3D plot of Figure 2 (B) merges the 
values of response time measured when the current reaches 95% of Ilim (t95%) (B). 
All responses were obtained from amperometric experiments performed at +0.65 V 
for ten successive additions of glucose 0.2 mM at CNT-muc/albumin with 1.33 U 
GOx. 
The mass ratio of CNT-muc/alb and the concentration values of 
glutaraldehyde that were employed for the construction of those enzymatic 
matrixes of biosensors were 0.0/100, 30/70, 50/50, 70/30, and 100/0 % w/w and 
0.1, 1.0, 5.0, 10.0, and 25.0 % v/v, respectively. Every data point corresponds to 
analytical parameters averaged from at least 2 calibration curves. All biosensors 
presented a linear response between the steady-state current and the analyzed 
range of glucose concentration with squared correlation coefficient (Adj. R-Square) 
equal to 0.999. Adj. R-Square or R2 can be used indifferently along of the 
manuscript. 
Another important issue is that the inherent good hydrophilic character of 
these hydrogel matrixes provides a biocompatible microenvironment for 
maintaining the catalytic activity of enzyme. In this sense, Colombo et al. 
demonstrated that the concentration of GOx within the hydrogel is an important 
variable in the development of the optimal sandwich-type glucose biosensor [12]. 
Besides, they demonstrated that a matrix prepared with very high amount of 
enzyme would not necessarily increase the analytical signal. This is because 
above certain concentration of the enzyme, the sensitivity is determined by the 
diffusion of the analyte through the different layers of the biosensor. In this regard 
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they have indicated that, for a similar enzymatic matrix, the addition of more than 
1.33 U of GOx per biosensor does not necessarily represent an increment on the 
sensitivity of the biosensor [12], [16]. Actually, this is one of the most important 
reasons for including CNT in the composition of the enzymatic matrix. The 
inclusion of CNT would decrease the viscosity of the hydrogel, enhancing the 
diffusion rate of reagents and products of the enzymatic reaction. 
The effect of glutaraldehyde on the glucose biosensor performance is in 
direct relationship to the activity of covalently immobilized enzyme, Fig. 2A. Ilim is 
the lowest when the enzymatic matrices are prepared with 0.1 % v/v and 0.0 % v/v 
(not shown) of glutaraldehyde. This behavior can be explained considering that 
those hydrogel matrices were prepared with low amount of glutaraldehyde. Since 
those hydrogels were not significantly crosslinked, GOx would escape from the 
enzymatic matrix during the washing step and subsequent amperometric 
experiments. The sensitivity of the biosensor improves when the concentration of 
glutaraldehyde is increased from 1.0 % v/v to 5.0 % v/v, but it decreases for 
greater amounts of glutaraldehyde than 10.0 % v/v. This behavior demonstrates 
the effect of the crosslinking reaction. In this regard, a high concentration of 
glutaraldehyde would not only limit the diffusion of reagents, but also deactivate 
part of the enzyme. Since albumin is the protein with the highest amount of amino 
groups of the mixture its presence is essential for the elastic properties of the 
hydrogel. In this regard, enzymatic matrixes with less than 10.0 % w/w albumin do 
not have the consistence of a hydrogel irrespectively of the concentration of 
glutaraldehyde.  
The biosensors prepared with a concentration of glutaraldehyde within the 
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range of 5.0 % v/v and 10.0 % v/v have practically the same sensitivity, 
irrespectively of the composition of the enzymatic matrix. Besides, this set of 
biosensors present some of the highest values of sensitivity. For instance, the 
sensitivity of a biosensor containing 50 % w/w CNT-muc and 50 % w/w alb (Pt-
CNT-muc 50%) is practically 2.5 times larger for a sensor prepared with 5.0 % v/v 
of glutaraldehyde than for a similar one prepared with 25.0 % v/v of crosslinker. A 
high level of crosslinking will have strong impact on the biocatalytic activity of the 
enzyme because it would produce conformational changes in the recognition 
element and condition the diffusion of reagents and products through the matrix. 
As a consequence, not only the sensitivity will be low, but also the response-time 
will be high for those biosensors prepared with high amount of glutaraldehyde. 
For this reason, the optimum composition of this type of biosensors was 
based on selecting the composition that provides not only the highest sensitivity, 
but also the shortest response-time when exposed to a sample with glucose. In 
general, sandwich-type biosensors built with CNT-muc have shown higher 
sensitivity than those made with mucin [12]. For example, the maximum sensitivity 
observed for the set of biosensors analyzed in Figure 2(A) was equal to 0.52 ± 
0.04 mA.M−1, and corresponds to the enzymatic matrix prepared with 5.0% v/v of 
glutaraldehyde and 30% of CNT-mucin. An equivalent study performed for a 
biosensor prepared without CNT showed a sensitivity of 0.38 ± 0.02 mA.M−1 [12]. 
Therefore, the sensitivity of the biosensor increased more than 35% due to the 
inclusion of CNT into the hydrogel. With regards to the response-time of the 
biosensor, Figure 2B shows how this parameter changes with the composition of 
the biosensor. As a general behavior, it can be observed that the response-time of 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
 
the biosensor increases when the concentration of glutaraldehyde is changed from 
1.0 to 25.0 % v/v. However, it is interesting to notice that the values of response-
time depend markedly on the percentage of CNT-muc. In this regard, those 
matrices built with 0.0; 10.0 and 30.0% w/w CNT-muc presented the highest values 
of response-time, while the lowest correspond to those biosensors prepared with 
50% of CNT-muc. The minimum response-time of the set of biosensors was 28 ± 2 
s and it corresponds to the enzymatic matrix prepared with 50% of CNT-muc and 
glutaraldehyde diluted to 5.0 % v/v. This value of response-time is 25% better than 
that achieved with a similar biosensor, but prepared without CNT [12]. 
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Fig. 2 Dependence of (A) sensitivity (Ilim.Cgluc-1) and (B) response-time at 95% of 
Ilim (t95%) on the % of glutaraldehyde ([Glut]) and on the mass ratio of CNT-muc 
(mCNT.muc) and albumin (mAlb) employed for the enzymatic matrix. The time for the 
crosslinking reaction was 5 min and required 1.33 U GOx per sensor. 
 
As it was observed, the inclusion of CNT into the hydrogel would contribute 
to enhance the sensitivity and reduce the response time of the biosensor.           
Figure 3 exhibits the dependence of the ratio between sensitivity and response-
time on the percentages of CNT-muc and glutaraldehyde used for the biosensor 
construction. Based on these results, a 50.0% w/w of CNT-muc and 5.0% v/v of 
glutaraldehyde would be the best choice for preparing a biosensor with high 
sensitivity and fast response-time. The sensitivity of the proposed glucose 
biosensor was calculated to be 0.44 ± 0.01 mA.M−1. 
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Fig. 3 Relationship between sensitivity and response-time (Ilim.Cgluc-1.t95%-1) as a 
function of the % of glutaraldehyde and the CNT-muc/alb mass ratio employed for 
the construction of the enzymatic matrix. 
 
3.2. Detection limit and linear interval of the proposed biosensor 
According to the optimal conditions found in the previous experiments, a 
calibration curve was measured to determine the range in which the analytical 
response of the biosensor presents lineal behavior. The cell was initially filled with 
4.0 mL of 0.1 M phosphate buffer pH 7.0. The detection limit (LOD) and linear 
interval of the sensor were determined with glucose standard solutions of 1.0; 10.0 
and 100.0 mM. The calibration curve involved several additions of 8 µL and 24 µL 
of the different standard solutions to the electrochemical cell. The LOD of a 
biosensor was calculated as 3 times the ratio between the standard deviation of 
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the background current and the slope of the calibration curve. The standard 
deviation of the background current was calculated from the average of ten 
background currents recorded 50 s before the first injection of a glucose standard.  
Figure 4A shows a chronoamperometric curve corresponding to successive 
additions of glucose 0.002, 0.02, 0.2, and 0.6 mM for a biosensor prepared with 
50.0% w/w CNT-muc, 5.0% v/v of glutaraldehyde, and 1.33 U of GOx. The 
calibration curve was performed in 0.1M phosphate buffer, pH 7.0. The inset 
displays the amperometric response of the biosensor for the lowest concentrations 
of glucose. Fig. 4 B depicts a logarithmic plot elaborated with the data of the 
calibration curve. From this plot it can be clearly observed that the biosensor 
presents a wide range of linear behavior. It is important to notice that if the results 
were presented in a linear plot, most of the data corresponding to the lowest 
concentration values would merge as a single point. The linear range of the 
bioelectrode goes from 0.002 to 3.2 mM with a squared correlation coefficient R2 = 
0.997. Above a glucose concentration of 3.2 mM, the bio-electrochemical response 
is limited by the diffusion of glucose and O2, the natural mediator of this enzymatic 
reaction. Consequently, the current increases non-linearly with the glucose 
concentration, as expected for enzymatic reactions with a conventional ping-pong 
mechanism [12, 16, 20, 21]. 
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Fig. 4 (A) Chronoamperometric profile of a biosensor prepared with 
[Glutaraldehyde] = 5.0 % v/v, 50/50 CNT-muc/alb, CGOx= 1.33 U. (B) Logarithmic 
dependence of Ilim on [Glucose]. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
The analytical performance of the bioelectrode was compared with other 
glucose biosensors prepared with GOx, Table 1. The LOD obtained from                             
Pt-CNT-muc 50% was similar that of some recently reported amperometric 
biosensors based on the immobilization of GOx [12, 22–28]. It is necessary to 
emphasize that the biosensor reported here has excellent interval of linear 
behavior since the linear dependence involves more than 3 orders of magnitude. 
Moreover, it not only can be reused, but it also has high storage stability when 
compared to others [22], [25], [26], [28, [29], [34]. 
 
Table 1. Comparison of the analytical performance of glucose biosensors.  
Glucose biosensor Response 
time (sec) 
Sensitivity 
(mA.M-1.cm-2) 
Limit of 
detection 
(µM) 
Lineal 
Range 
(mM) 
AA 
Interference 
Stability 
(days) Ref. 
Pt-CNT-muc 50% 29 15 3 0.002-3.2 5% b 300 This 
work 
Au/Chitosan 
nanoparticles  2 157 1 0.001-1 Not Studied ≤ 10 [26] 
Pt-muc/alb 30/70% 35 9.4 3 0.003-3.5 Not Studied 210 [12] 
Fe3O4 nanoparticles 
polyvinyl alcohol 10  9360 
a
 8 0.005-30 5% b 30 c [32] 
Au–Ni noaxial 
nanorod array 13 770 6 0.03-26 Free 30 [27] 
Au/Glutaraldehyde - 
dialysis membrane 1200 1.6 10
-5 
  5×103 17-444 Free 10 [28] 
Pt/Nafion® - p-
MAA microparticles ~30  12 1×10
1
 0.009-8.3 Free 550 [33] 
Pt/PMEH 
(methacrylate 
copolymer) 
60 156 3 0.005-1 Not Studied 
≤ 0,25 
(Disposab
le) 
[24] 
Pt/Chitosan 
membrane 60 0.0019 5×10
1
  0.01-15 Not Studied ≤ 10 d  [34] 
SPCE/cellulose 
paper   ? 0.002 2×10
2
 1-5 5% b 120 [25] 
a
 mAM-1. b maximum physiological.  c the sensitivity after 30 days decreased 20%. d the sensitivity after 30 
days decreased 50%. LOD values have been expressed with one significant figure. 
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3.3. Selectivity of the proposed biosensor in presence of ascorbic acid 
Ascorbic acid (AA) is a typical interfering species when the bio-
electrochemical quantification of glucose, dissolved in blood plasma and other 
biologic fluids, is based on the oxidation of hydrogen peroxide. The effect of this 
potential interfering species on the response of the proposed biosensor was 
evaluated in 0.1 M PBS pH 7.0, when the physiological concentration of glucose 
found in blood human plasma (5.0 mM) is analyzed. The chronoamperometric 
response increased 5% after the addition of 0.1 mM of AA, not shown. The effect 
of AA on the biosensor selectivity was comparable to those reported for other 
similar glucose biosensors (5%) [25]. Thus, the maximum physiological 
concentrations of AA found in human blood plasma (0.1 mM) would not represent a 
relevant interference for the proposed biosensor [35], [36]. 
 
3.4. Sensor intra-day stability 
The stability of the bioelectrode was evaluated by performing several 
chronoamperometric measurements. Considering that each calibration curve 
consisted in 10 standard additions of glucose and that the comparison involved the 
slopes of 10 calibration curves for the same biosensor, it is clear that the sensor 
was used for the analysis of 100 samples. Figure 5 A shows the normalized 
sensitivity of ten calibration curves performed with a sandwich-type biosensor 
prepared with an enzymatic matrix composed by 50/50 CNT-muc/alb, 1.33 U GOx, 
and 5.0% v/v glutaraldehyde. Every addition of glucose increased the 
concentration of glucose in 0.2 mM. Figure 5 B shows the corresponding average 
plot of the 10 calibration curves. All calibration curves showed very similar values 
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of sensitivity. The relative standard deviation obtained for these 10 successive 
calibration curves was 6.4, evidencing the excellent short-term stability of the 
biosensor. 
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Fig. 5 A) Evolution of the sensitivity of the sensor as a function of number of 
calibration curves performed after its assembling. B) Average calibration curve 
corresponding to the ten profiles recorded after assembling the biosensor. The 
sensor was prepared with 1.33 U GOx, 50/50 CNT-muc/alb, 5% glutaraldehyde 
and stored in 0.10 M phosphate buffer pH 7.0. Additions correspond to 0.2 mM 
glucose.  
 
3.5. Stability of the proposed sandwich-type biosensor 
The long-term stability of the bioelectrode was analyzed by comparing the 
slopes of calibration curves corresponding to diverse chronoamperometric 
experiments performed with the same biosensor at +0.65 V. Calibration curves 
were collected two times per week for 2 months in order to analyze the storage 
stability of the biosensor. Between the measurements, the bioelectrode was stored 
in 0.1 M phosphate buffer pH 7.0 at 4 ◦C. During these 60 days, calibration curves 
kept their linear behavior up to 1.0 mM while the LOD value remained constant. 
During the first 10 days, the sensitivity of the biosensor increased almost 25 % with 
regards to the value measured at the first day of this experiment. After the 10th day 
the electrochemical response of the biosensor remained practically constant until 
the end of the study. In this regard, the average sensitivity of the biosensor was 
equal to 0.56 ± 0.03 mA.M−1. After all these measurements, the bioelectrode was 
stored for other extra 7 months. After this period, the biosensor showed an 
analytical sensitivity only 10 percent lower than observed after it preparation/ first 
day experiment. 
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3.6. Real samples 
Although the analysis of potential interfering species such as AA is indeed 
important, potential application for clinical analysis of this sandwich-type biosensor 
becomes evident when it is exposed to samples of blood human plasma. Real 
samples commonly involve several different species that limit the sensitivity and 
reproducibility of the proposed biosensor. As a result, a comparative analysis of the 
developed bioelectrode with a standard commercial method is highly desired to 
evaluate the real capabilities of the proposed biosensor. The samples were first 
analyzed with the standard bi-enzymatic method [37], [38] in the clinical laboratory 
of the Medical Center of Unión Obrera Metalúrgica, Córdoba, Argentina. Those 
samples were transferred to our laboratory and analyzed within 24 hs of their 
reception. 
Then, the glucose concentration values corresponding to a set of samples of 
human blood plasma, were measured using the biosensor. The biosensor used for 
this study was prepared with 50% w/w CNT-muc, 50% w/w albumin, 5.0% v/v of 
glutaraldehyde, and 1.33 U GOx. After observing a proper background current, 40 
µL of human blood plasma was added to a vial containing 4 mL of phosphate 
buffer pH 7.0. Figure 6A shows the chronoamperometric response of a) standard 
glucose (120mg.dl-1), b) physiologic plasma (80 mg.dL-1) and pathologic plasma                           
(205 mg.dL-1) recorded for about 400 s at +0.65 V. As seen in the image, this 
sensor presents an adequate response regardless of the glucose concentration 
and characteristics of the matrix. 
Subsequently, 10 samples of human blood plasma involved glucose 
concentration values that ranged from physiologic 80 mg.dL–1 to pathologic levels 
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304 mg.dL–1 [36] were analyzed. This comparative study showed a linear 
relationship with a correlation factor R2 = 0.991, which is a quite high value 
considering that some of these clinical samples might present different 
electroactive species such as uric acid or bilirubin due to their pathologic 
characteristics. Each value of glucose concentration informed in this plot 
corresponds to the average obtained from 4 repeated determinations. The 
developed biosensor demonstrated a 4.0 % average systematic error (% BIAS) 
when compared with the values determined by the standard method. The response 
of the sandwich-type glucose biosensor to human blood plasma was highly 
reproducible, providing a residual standard deviation (% RSD) of 2.2 % for the set 
of evaluated samples. Once this comparative analysis was finished, the extra 
amount of six human blood samples was stored in the fridge at -20 °C. Also, the 
sandwich sandwich-type biosensor was rinsed with deionized water and stored in 
phosphate buffer pH 7.0 at 4 °C. After 21 days, the  comparison of the methods 
was repeated with the remaining six human blood samples. These samples of 
human blood plasma also involved physiologic and pathologic levels of glycaemia 
(80 to 304 mg.dL-1). Under these conditions, a linear correlation was obtained with 
an R2 value of 0.989. In this opportunity, the comparison with the results of the 
medical center showed a % BIAS of 3.7 and a % RSD of 4.7%. The comparison 
between the results obtained for the proposed bioelectrode and the standard 
spectrophotometric method indicates a quite good analytical performance of Pt-
CNT-muc 50 %. Those results would also indicate that the biosensor can be used 
for measuring the concentration of glucose in samples of blood plasma with the 
usual interfering species.  
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Fig. 6 A) Amperometric response of a biosensor prepared with 1.33 U GOx, 50/50 
CNT-muc/alb, 5% glutaraldehyde after addition of a) standard glucose                    
(120mg.dl-1), b) physiologic plasma (80 mg.dL-1) and pathologic plasma                                              
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(205 mg.dL-1)  B) Comparison of the plasma glucose measurement performed with 
the biosensor and the standard method used in a clinical laboratory. 
 
4. CONCLUSIONS 
In this manuscript, the development and optimization of an electrochemical 
sandwich-type glucose biosensor has been presented. In this opportunity, a blend 
of CNT with mucin and albumin was prepared as the scaffold of the enzymatic 
matrix. The analytical performance of biosensor depends on the ratio of CNT-
muc/alb as well as on the amount of crosslinker employed for the enzymatic matrix. 
The best relationship between sensitivity and response-time of the different 
biosensors corresponds to the enzymatic matrix composed by 50% w/w of CNT-
muc, 50% w/w albumin, 1.33 U GOx per biosensor, and 5.0 % v/v of 
glutaraldehyde.  
The developed sandwich-type glucose biosensor showed higher sensitivity 
and lower response-time than a previous biosensor prepared in our group without 
CNT. The incorporation of CNT to the enzymatic matrix would reduce the viscosity 
of the enzymatic matrix and thus, the diffusion coefficients of reagents and 
products of the enzymatic reaction would be higher than those of an enzymatic 
matrix without CNT. As a result of this, the concentration of glucose would increase 
inside the enzymatic matrix, providing higher analytical response to the biosensor. 
This hypothesis is also consistent with the diminution of the response-time of the 
biosensor.  
The linear response of the sensor engages solutions with glucose 
concentrations that range from micro to millimolar. Considering that most 
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intermittent use biosensors commonly involve the dilution of samples, between 20 
and 200 times, the dynamic range of the biosensor widely encompasses the 
feasible glucose concentrations of human blood plasma corresponding to healthy 
and diabetic patients. Moreover, this biosensor has not only demonstrated good 
repeatability, reproducibility, and intra-day stability in presence of standard 
solutions of glucose, but also for the analysis of real samples of blood plasma.  
The very good long-term stability observed under storage and intermittent 
use conditions points out that the developed biosensor can be used for systematic 
quantification of glucose in real biological system. These results make this 
biosensor in a suitable alternative for glucose determination in diabetic patients, 
since it represents a very economical, robust, and highly sensitive platform for the 
quantification of glucose in complex samples. In this sense, it would be also quite 
simple to adapt this analytical methodology for measuring the concentration of 
glucose in other samples such as fruit and vegetables. This is also desirable for 
diabetic patients, because the fruit-ripening process is closely associated with an 
increasing glucose level. 
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